Scynexis
Price & Volume
Stats
See more52W Range | $0.56-$1.31 |
Market Cap | $78.6M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $20.6M |
Revenue Growth (YoY) | 1,808.5% |
Gross Profit (12 Mos) | $20.6M |
Diluted EPS | -$0.17 |
News
See moreYahoo Finance • 4 months ago
SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
Yahoo Finance • 6 months ago
SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK
Yahoo Finance • 6 months ago
Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections
Yahoo Finance • 6 months ago
SCYNEXIS Reports Third Quarter 2025 Financial Results and Provides Corporate Update
About
CEO | Dr. David Gonzalez Angulo M.D. |
Address | 1 Evertrust Plaza, Jersey City, NJ, United States, 07302-6548 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 18 |